BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20228957)

  • 1. Radioimmunotherapy of infection with Bi-labeled antibodies.
    Dadachova E
    Curr Radiopharm; 2008 Sep; 1(3):234-239. PubMed ID: 20228957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of infection with radiolabeled antibodies.
    Dadachova E; Casadevall A
    Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):193-204. PubMed ID: 16868533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
    Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
    J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of infectious diseases.
    Dadachova E; Casadevall A
    Semin Nucl Med; 2009 Mar; 39(2):146-53. PubMed ID: 19187806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection.
    Dadachova E; Bryan RA; Apostolidis C; Morgenstern A; Zhang T; Moadel T; Torres M; Huang X; Revskaya E; Casadevall A
    J Infect Dis; 2006 May; 193(10):1427-36. PubMed ID: 16619191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections.
    Helal M; Allen KJH; Burgess H; Jiao R; Malo ME; Hutcheson M; Dadachova E; Snead E
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32784359
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma.
    Supiot S; Faivre-Chauvet A; Couturier O; Heymann MF; Robillard N; Kraeber-Bodéré F; Morandeau L; Mahé MA; Chérel M
    Cancer; 2002 Feb; 94(4 Suppl):1202-9. PubMed ID: 11877746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical testing of radiopharmaceuticals for novel applications in HIV, bacterial and fungal infectious diseases.
    Shah M; Garg G; Dadachova E
    Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):317-26. PubMed ID: 26200222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens.
    Bryan RA; Guimaraes AJ; Hopcraft S; Jiang Z; Bonilla K; Morgenstern A; Bruchertseifer F; Del Poeta M; Torosantucci A; Cassone A; Nosanchuk JD; Casadevall A; Dadachova E
    Mycopathologia; 2012 Jun; 173(5-6):463-71. PubMed ID: 22048869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody.
    Helal M; Allen KJH; van Dijk B; Nosanchuk JD; Snead E; Dadachova E
    Front Microbiol; 2020; 11():147. PubMed ID: 32117166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model.
    Fichou N; Gouard S; Maurel C; Barbet J; Ferrer L; Morgenstern A; Bruchertseifer F; Faivre-Chauvet A; Bigot-Corbel E; Davodeau F; Gaschet J; Chérel M
    Front Med (Lausanne); 2015; 2():76. PubMed ID: 26582128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
    Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cells.
    Garg R; Mills K; Allen KJH; Causey P; Perron RW; Gendron D; Sanche S; Berman JW; Gorny MK; Dadachova E
    Nucl Med Biol; 2020; 82-83():80-88. PubMed ID: 32113033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium.
    Allen KJH; Jiao R; Malo ME; Frank C; Fisher DR; Rickles D; Dadachova E
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31323785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled antibodies for therapy of infectious diseases.
    Dadachova E; Casadevall A
    Microbiol Spectr; 2014 Nov; 2(6):0023. PubMed ID: 25599011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy as a Novel Approach in HIV, Bacterial, and Fungal Infectious Diseases.
    Helal M; Dadachova E
    Cancer Biother Radiopharm; 2018 Oct; 33(8):330-335. PubMed ID: 30133305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status and perspectives in alpha radioimmunotherapy.
    Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections.
    Dadachova E; Casadevall A
    Interdiscip Perspect Infect Dis; 2011; 2011():830286. PubMed ID: 21747848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody.
    Huber R; Seidl C; Schmid E; Seidenschwang S; Becker KF; Schuhmacher C; Apostolidis C; Nikula T; Kremmer E; Schwaiger M; Senekowitsch-Schmidtke R
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3922S-8S. PubMed ID: 14506190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.